Biotech

All Articles

Lundbeck indications $2.5 B check for Longboard as well as its epilepsy med

.After snooping runaway success possibility in Longboard Pharmaceuticals' epilepsy med, brain diseas...

Lilly picks UK for first Entrance Lab in Europe

.Eli Lilly's Gateway Labs is going worldwide, along with the U.K. government declaring today that th...

Jasper dials up dose after colonies reactions reoccur quickly

.Jasper Therapy has mentioned total responses in 10 of the 12 severe colonies clients that got the h...

Transgene's popular cancer cells vaccine fails midphase exam

.Transgene's curative vaccination applicant TG4001 has actually flunked a period 2 sound tumor test....

Upstream swells IPO to $255M as it specifies together with CAMP4

.Upstream Bio possesses puffy its own IPO to $255 thousand as the business joins CAMP4 Therapies tod...

Sanofi flunks MS research, dealing an additional blow to Denali pact

.Sanofi has ceased a phase 2 difficulty of Denali Therapeutics-partnered oditrasertib in various scl...

Turnstone lays off 60%, agitates C-suite to extend money

.Turnstone Biologics is actually reducing its own head count by 60% and also agitating its C-suite t...

Gilead quits on $15M MASH wager after reviewing preclinical data

.In a year that has seen a confirmation as well as a plethora of readouts for metabolic dysfunction-...

Texas biotech centers cancer cells contract, pins wishes on being overweight

.Alaunos Rehabs is axing a contract with Precigen, losing hope licensing civil liberties to a tailor...

Capricor allotments more information for DMD therapy after starting BLA

.Capricor Rehabs is taking a victory tour for their period 2 Duchenne muscular dystrophy (DMD) test....